Awareness of the use of folic acid to prevent neural tube defects in a Mediterranean area

被引:54
作者
Coll, O
Pisa, S
Palacio, M
Quintó, L
Cararach, V
机构
[1] Univ Barcelona, Hosp Clin, Inst Clin Ginecol Obstet & Neonatol, Serv Obstet, E-08028 Barcelona, Spain
[2] Univ Barcelona, Hosp Clin, Unitat Epidemiol & Bioestadist, E-08036 Barcelona, Spain
来源
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 2004年 / 115卷 / 02期
关键词
folic acid; neural tube defects; periconceptional use;
D O I
10.1016/j.ejogrb.2003.12.009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: The risk of neural tube defects (NTDs) is decreased in women who take folic acid during the periconceptional period. The main objective of our study was to evaluate the awareness of the need for folic acid supplementation and also the actual intake during the periconceptional period to prevent neural tube defects in a Mediterranean area. Study design: A retrospective study was performed from 1 July to 30 November 2000. One thousand consecutive women who delivered in our hospital were interviewed during the immediate postpartum period about their knowledge of neural tube defects and folic acid intake before and during pregnancy. Results: Most women (85.7%) referred not having been specifically informed about the need to take folic acid to prevent neural tube defects although approximately half of the women (50.6%) were in fact, aware of the need for folic acid intake. Eight percent (8.1%) of the women took folic acid before conception but only 6.9% did so during the effective period from 4 weeks before conception to 4 weeks after conception. Logistic regression analysis showed that awareness of the need to take folic acid together with having had preconceptional counselling and knowledge of NTDs were the strongest variables related to the fact of having taken folic acid during the correct period. Conclusions: Although the population is aware of the need to take folic acid, the real impact of the present recommendations is almost negligible. Information in primary care and preconceptional counselling to specifically inform patients about the need to take folic acid to prevent NTDs seem to be crucial to improve the final intake of folic acid during the protective period. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 19 条
[1]  
AHLUWALIA IB, 2001, MMWR-MORBID MORTAL W, V50, P1
[2]   Periconceptional folic acid intake in Nijmegen, Netherlands [J].
Bekkers, RLM ;
Eskes, TKAB .
LANCET, 1999, 353 (9149) :292-292
[3]   Prevention of neural-tube defects with folic acid in China [J].
Berry, RJ ;
Li, Z ;
Erickson, JD ;
Li, S ;
Moore, CA ;
Wang, H ;
Mulinare, J ;
Zhao, P ;
Wong, LYC ;
Gindler, J ;
Hong, SX ;
Correa, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (20) :1485-1490
[4]   Knowledge of periconceptional folic acid for the prevention of neural tube defects - The missing links [J].
Bonin, MM ;
Bretzlaff, JA ;
Therrien, SA ;
Rowe, BH .
ARCHIVES OF FAMILY MEDICINE, 1998, 7 (05) :438-442
[5]  
BOOME K, 1999, MMWR-MORBID MORTAL W, V48, P914
[6]  
CDC (Cent. Dis. Control Prev.), 1992, MMWR RECOMM REP, V41, P1
[7]   PREVENTION OF THE 1ST OCCURRENCE OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATION [J].
CZEIZEL, AE ;
DUDAS, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (26) :1832-1835
[8]   Three years after the dutch folic acid campaign: Growing socioeconomic differences [J].
de Walle, HEK ;
Cornel, MC ;
de Jong-van den Berg, LTW .
PREVENTIVE MEDICINE, 2002, 35 (01) :65-69
[9]  
Food and Drug Administration U.S., 1996, Final Rule, V21, P8781
[10]  
GIBERT MJ, 2000, PROG OBSTET GINECOL, V43, P13